• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Spectranetics Corp.

Medtech manufacturers must add warning label to drug-eluting PAD devices

June 16, 2020 By Nancy Crotti

UK medtech regulators on Monday announced that manufacturers of paclitaxel-eluting balloons for use in peripheral arteries must add a warning label about the devices’ risks. A meta-analysis published in the Journal of the American Heart Association in 2018 suggested that patients treated with paclitaxel-coated balloons and stents for peripheral artery disease could be at a higher risk for […]

Filed Under: Business/Financial News, Drug-Device Combinations, Drug-Eluting Stents, Featured, Regulatory/Compliance, Stents, Vascular Tagged With: B. Braun, Biosensors International Group Ltd., Biotronik, Boston Scientific, Cook Medical, FDA, Lutonix Inc., LVD Biotech, Medtronic, Spectranetics Corp., U.K.medicinesandhealthcareproductsregulatoryagency

ViewRay picks up ex-Spectranetics CEO Drake, COO Matin | Personnel Moves – July 25, 2018

July 25, 2018 By Fink Densford

ViewRay (NSDQ:VRAY) said yesterday it tapped former Spectranetics head Scott Drake as its new chief executive officer and former Spectranetics COO Shar Matin as its new COO. Before joining ViewRay, Drake served as CEO and prez of Spectranetics, which was acquired by Royal Philips (NYSE:PHG) in a deal that closed last August. Drake also serves as board chair […]

Filed Under: Business/Financial News Tagged With: Alphabet (Google), avitamedical, Bonesupport, Clinical Innovations, intentsolutions, ohiomedical, Olympus, Personnel Moves, Philips, Procyrion, Spectranetics Corp., ViewRay Inc.

Veryan’s helical stent meets safety, efficacy endpoints after 12 months

February 9, 2018 By Sarah Faulkner

Veryan‘s helical BioMimics 3D stent met its primary safety and efficacy endpoints in a study of 271 patients with symptomatic femoropopliteal artery disease, according to TCTMD. The device, which is shaped to mimic the natural geometry of human vasculature, compared favorably with drug-coated balloons and stents. The probability of maintaining primary patency after 12 months was […]

Filed Under: Clinical Trials, Drug-Device Combinations, Pharmaceutical, Vascular, Wall Street Beat Tagged With: C.R. Bard, Cook Medical, Medtronic, Spectranetics Corp., Veryan

These 10 medtech companies care a lot about research

November 29, 2017 By Chris Newmarker

Among the world’s largest medtech companies, these 10 spent the largest portion of their budgets on research and development. So what have they produced? Every year, Medical Design & Outsourcing pulls financial regulatory filings and reaches out to major, companies in some cases to create a list of the 100 largest medical device companies in […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Research & Development Tagged With: Abiomed, Accuray Inc., Analogic, AtriCure Inc., Big 100, BioMerieux Inc., cochlear, Dexcom, Edwards Lifesciences, Insulet, Philips, Spectranetics Corp.

Philips subsidiary Spectranetics recalls Bridge occlusion balloon

August 31, 2017 By Brad Perriello

Royal Philips (NYSE:PHG) subsidiary Spectranetics recalled its Bridge occlusion balloon after receiving reports of blocked guidewire lumens. The Bridge device is used to temporarily block the superior vena cava for emergency control of hemorrhage. Spectranetics said the August 25 recall was prompted by nine reports of blocked guidewire lumens, although no deaths or serious injuries were […]

Filed Under: Cardiovascular, Catheters, Recalls Tagged With: Philips, Spectranetics Corp.

Philips closes $2B Spectranetics acquisition

August 10, 2017 By Fink Densford

Royal Philips (NYSE:PHG) said yesterday it closed its $2.2 billion deal to acquire US vascular intervention device maker Spectranetics (NSDQ:SPNC). With the closure, Spectranetics and its financial results will be consolidated into Philips image-guided therapy business, the company said. Philips said that Spectranetics employs over 900 individuals and is currently posting double-digit growth, with projected 2017 sales […]

Filed Under: Business/Financial News, Mergers & Acquisitions Tagged With: Philips, Spectranetics Corp.

Spectranetics wins FDA nod for Stellarex DCB

July 27, 2017 By Sarah Faulkner

Spectranetics (NSDQ:SPNC) said today that its Stellarex drug-coated balloon won FDA pre-market approval. The device is designed to treat patients with peripheral arterial disease, bringing blood flow back to the superficial femoral and popliteal arteries. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance, Vascular, Wall Street Beat Tagged With: Spectranetics Corp.

Philips to pay $2B for Spectranetics, plans $1.7B share buyback

June 28, 2017 By Brad Perriello

Royal Philips (NYSE:PHG) and Spectranetics (NSDQ:SPNC) said today that they agreed to a deal worth more than $2 billion that will see the Dutch healthcare giant take over the U.S. medical device maker. The $38.50-per-share deal values Spectranetics at $2.16 billion (€1.9 billion), including cash and debt, and is a 27% premium on SPNC’s $30.40 closing price […]

Filed Under: Mergers & Acquisitions, Vascular, Wall Street Beat Tagged With: Philips, Spectranetics Corp.

Spectranetics touts 100% survival rate in Bridge occlusion balloon study

May 12, 2017 By Fink Densford

Spectranetics (NSDQ:SPNC) today released data from a late breaking clinical trial of its Bridge occlusion balloon designed to reduce blood loss due to superior vena cava tears during lead extraction procedures, touting a 100% survival rate amongst patients treated with the balloon. The company presented 1-year clinical experience data from the study today at the Heart Rhythm […]

Filed Under: Cardiovascular, Catheters, Clinical Trials Tagged With: Spectranetics Corp.

Spectranetics shares rise on Q4, FY2016 beat

February 24, 2017 By Fink Densford

Shares in Spectranetics (NSDQ:SPNC) rose today after the medical device maker beat expectations on Wall Street with its 4th quarter and fiscal year 2016 earnings report. The Colorado Springs, Colo.-based company posted losses of $12.6 million, or 29¢ per share, on sales of $71.9 million for the 3 months ended Dec.31, with losses on the […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup Tagged With: Spectranetics Corp.

Xtant Medical CEO Goldberger steps down | Personnel Moves | February 3, 2017

February 3, 2017 By Brad Perriello

Xtant Medical (NYSE:XTNT) said that CEO Dan Goldberger resigned effective Jan. 21 “to pursue other interests.” The Belgrade, Mont.-based company, which was formed after Bacterin paid $86 million for spinal implant maker X-Spine Systems, said president Carl O’Connell will step in as interim CEO while the company’s board “contemplates the permanent CEO,” according to a […]

Filed Under: Business/Financial News Tagged With: AdvaMed, Guided Therapeutics Inc., Personnel Moves, reflexion-health, ResMed Inc., Sequana Medical AG, Spectranetics Corp., Titan Spine, Valeritas, Xtant Medical

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 7
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS